Item 7.01 Regulation FD Disclosure.
Monthly Operating Report
On
The information contained in this Item 7.01, including Exhibit 99.1 incorporated by reference herein, is being furnished under Item 7.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing. The filing of this Current Report on Form 8-K shall not be deemed an admission as to the materiality of any information herein that is required to be disclosed solely by reason of Regulation FD.
Cautionary Note Regarding the Monthly Operating Report
Investors and potential investors should not place undue reliance on the
information contained in the Monthly Operating Report, which was not prepared
for the purpose of providing the basis for an investment decision relating to
any securities of the Company. The Monthly Operating Report is limited in scope,
covers a limited time period, and has been prepared solely for the purpose of
complying with the requirements of the
Item 8.01 Other Events. Cessation of Patient Support
The Company is permanently ending its operations. This decision is a result of
the sale of the Company's intellectual property and certain other assets to
This means: ? The Company has ceased all field patient support, product warranty replacements and treatment activities, effective immediately. ? The Company will continue to provide patient support by phone through confirmation of the Plan of Liquidation of Nuvectra Corporation Under Chapter 11 of the Bankruptcy Code (the "Plan"), which may be as early asApril 17, 2020 . Thereafter, those services will not be available. ? The Company cannot provide adjustments to therapy or reprogramming. ? MRIs can no longer be cleared and the conditions for MRIs cannot be met. ? The Company is no longer offering patient education or troubleshooting programs.
--------------------------------------------------------------------------------
? Programmer or equipment replacements are no longer available - it is vital that patients keep their current products charged at this time.
The Company cannot make specific recommendations regarding patient medical care, and the Company urges patients to consult their physician if they have questions about keeping or removing their device.
Update Regarding Confirmation Hearing
Due to the ongoing coronavirus (COVID-19), it is anticipated that the
confirmation hearing with respect to the Plan, previously scheduled for
Additional Information Regarding the Chapter 11 Case
Filings with the
Item 9.01 Financial Statements and Exhibits. (d) Exhibits
99.1 Monthly Operating Report for the month ended
with theBankruptcy Court onMarch 25, 2020
--------------------------------------------------------------------------------
© Edgar Online, source